Dr. Bio....I sold, but that doesn't mean I will not get back in. I am waiting to see which direction Yak takes with respect to marketing and partnering. To me the key is whether BP believes the data package from the CRO---who is INC., will win approval. I also believe that landing an SPA with the FDA for the diabetic indication will be a major incentive for a partner to sign-on. I'm not in love with management here, would like to see them partner Neurodex instead of dreaming they can launch this drug on their own.
Regards,
katie....